Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission.

Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission.

Item
http://www.wikidata.org/entity/Q39699155
Leptin and its receptor in hematologic malignanciesNeutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.Association of differential gene expression with imatinib mesylate and omacetaxine mepesuccinate toxicity in lymphoblastoid cell lines.Neutrophil gelatinase-associated lipocalin increases HLA-G(+)/FoxP3(+) T-regulatory cell population in an in vitro model of PBMC.Leptin modification in chronic myeloid leukemia patients treated with imatinib: An emerging effect of targeted therapy.Concentrations of adipokines in children before and after hematopoietic stem cell transplantation.Higher lipocalin 2 expression may represent an independent favorable prognostic factor in cytogenetically normal acute myeloid leukemia.Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?
P2860

Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission.

Item
http://www.wikidata.org/entity/Q39699155
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Imatinib mesylate therapy indu ...... tients in molecular remission.
@en
Imatinib mesylate therapy indu ...... tients in molecular remission.
@nl
type
label
Imatinib mesylate therapy indu ...... tients in molecular remission.
@en
Imatinib mesylate therapy indu ...... tients in molecular remission.
@nl
prefLabel
Imatinib mesylate therapy indu ...... tients in molecular remission.
@en
Imatinib mesylate therapy indu ...... tients in molecular remission.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Imatinib mesylate therapy indu ...... tients in molecular remission.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921